US$ 27.88
semaglutide pregnancy discontinue before conception GLP-1 receptor agonists and preconception planning: bridging the gap between obesity treatment and reproductive safety, a narrative review If you're on a GLP-1
Description
At JosephCareRX, we understand that determining your eligibility for certain medical treatments or procedures is an important step in your healthcare journey
Liraglutide has a longer overall safety track record, having been approved for weight management since 2015, compared with tirzepatide, which was approved in 2023

Wegovy 7.2mg: 20.7% average weight loss at 72 weeks (STEP UP, Lancet 2025)

That gap is more than $10,000 a year on identical active ingredient
8 March 2023: